Targeting miR-375 in gastric cancer

Author： Xu Yanjun Deng Yujie Yan Xiaoyi Zhou Tianhua

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.8, 2011-08, pp. : 961-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 503-508

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1917-1923

Bentham Science Publishers

Access to resources Recommend Favorite

miR-210: a therapeutic target in cancer

By Hong Liu Han Yu Zhang Hongwei Zhao Qingchuan Qiao Yuan

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite

miR-149 as a Potential Molecular Target for Cancer

Current Medicinal Chemistry, Vol. 25, Iss. 9, 2018-03 ,pp. : 1046-1054

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting miR-205 in breast cancer

By Wu Hailong Mo Yin-Yuan

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 12, 2009-12 ,pp. : 1439-1448

Informa Healthcare

Access to resources Recommend Favorite